Currently, the only available vaccine against tuberculosis is Mycobacterium bovis Bacille Calmette-Guérin (BCG). Pulmonary tuberculosis protection provided by the vaccine varies depending on the strain, the patient’s age and the evaluated population. Although the adaptive immune responses induced by different BCG strains have been widely studied, little conclusive data is available regarding innate immune responses, especially in macrophages. Here, we aimed to characterize the innate immune responses of human THP-1-derived macrophages at the transcriptional level following a challenge with either the BCG Mexico (M.BCG) or Phipps (P.BCG) strains. After a brief in vitro characterization of the bacterial strains and the innate immune responses, including nitric oxide production and cytokine profiles, we analyzed the mRNA expression patterns and performed pathway enrichment analysis using RNA microarrays. Our results showed that multiple biological processes were enriched, especially those associated with innate inflammatory and antimicrobial responses, including tumor necrosis factor (TNF)-α, type I interferon (IFN-I) and IFN-γ. However, four DEGs were identified in macrophages infected with M.BCG compared to P. BCG. These findings indicated the proinflammatory stimulation of macrophages induced by both BCG strains, at the cytokine level and in terms of gene expression, suggesting a differential expression pattern of innate immune transcripts depending on the mycobacterial strain.
The development of new tuberculosis vaccines remains a global priority, and recombinant vaccines are a frequently investigated option. These vaccines follow a molecular strategy that may enhance protective efficacy. However, their functional differences, particularly with respect to glycosylation, remain unknown. Recent studies have shown that glycosylation plays a key role in the host-pathogen interactions during immune recognition. The aim of this study was to determine the differences in the glycosylation profiles of two recombinant strains of Mycobacterium microti, overexpressing Ag85B (Rv1886c) and PstS-1 (Rv0934) antigens of M. tuberculosis. For each strain, the glycosylation profile was determined by Western blotting with lectins. The results showed the presence of mannosylated proteins and evidence of linked sialic acid proteins. Interestingly, different proteome and glycoproteome profiles were observed between the two recombinant strains and the wild-type strain. We have shown here that the construction of the recombinant strains of M. microti has altered the proteome and glycosylation profiles of these strains, leading us to ask what impact these changes might have on the immune response.
Resistance to several antibiotics against Mycobacterium tuberculosis is a serious problem to be solved worldwide. In the present work, we made the statistical analysis of the gene regulatory network of Mycobacterium tuberculosis and of the Mycobacterium tuberculosis -macrophage interactome to find the probable cause of this resistance. The results from this analysis show that both the gene regulatory network and the interactoma have a hierarchical free scale modular structure that assures a high degree of resilience of these networks against external perturbations. In particular, the interactome is a complex hybrid network that results from the formation of novel links between the Mycobacterium tuberculosis and macrophage proteins and from the modification of the previously existing links between the native macrophage proteins, which give rise to novel negative and positive feedback loops that modify the dynamical behavior of the interactome and protect the mycobacterium against the attack with antibiotics by taking control of the macrophage immune response and apoptosis. The statistical analysis of the interactome shows that the highly connected mycobacterium proteins inhA, ahpC, kasA, katG and rpsL exert this control by creating new links with the host proteins FAS and NF-κB. These new hybrid circuits embedded in the hierarchical scale-free modular molecular structure of the interactome produce its high resistance to external perturbations like antibiotics. As consequence, the present work proposes the hypothesis that Mycobacterium tuberculosis antibiotic resistance in vivo during chronic tuberculosis is only a particular case of a more complex problem that is the interactome resilience against antibiotics. Thus, new strategies of drug design are necessary to shatter the complex structure of the Mycobacterium tuberculosis -macrophage interactome.
25 April 2017 in International Journal of Pulmonary & Respiratory Sciences
International journal of Pulmonary & Respiratory Sciences is an internationally accepted, Peer reviewed, online journal which deals with the publishing of high quality articles related to all branches of Pulmonary & Respiratory systems.